Blake Byers
Founder bei Newlimit, Inc
Profil
Blake Byers is the founder of Byers Capital, Newlimit, Inc. He is currently a Director at IonQ Quantum, Inc. He previously served as Chairman & President at PACT Pharma, Inc. and held director positions at Lendup Global, Inc., Spotlight Therapeutics, Inc., and dMY Technology Group, Inc. III.
He was also an Independent Director at Magenta Therapeutics, Inc. from 2017 to 2021.
Dr. Byers started his career as an Associate at Morgan Stanley in 2006.
He is a General Partner at GV Management Co. LLC.
Dr. Byers received his undergraduate degree from Duke University in 2007 and his graduate and doctorate degrees from Stanford University.
Aktive Positionen von Blake Byers
| Unternehmen | Position | Beginn |
|---|---|---|
IonQ Quantum, Inc.
 IonQ Quantum, Inc. Computer Processing HardwareElectronic Technology IonQ Quantum, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jungsang Kim in 2015 and is headquartered in College Park, MD. | Director/Board Member | 01.02.2017 |
| Byers Capital | Founder | - |
Newlimit, Inc
 Newlimit, Inc BiotechnologyHealth Technology Newlimit, Inc has developed a tool that combines various work applications into a single workspace for individuals and teams. The company is located in the US. The American company is also focused on extending human healthspan by unlocking regenerative potential and treating age-related diseases. | Founder | - |
Ehemalige bekannte Positionen von Blake Byers
| Unternehmen | Position | Ende |
|---|---|---|
| IONQ, INC. | Director/Board Member | 07.12.2022 |
| MAGENTA THERAPEUTICS | Director/Board Member | 01.06.2021 |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Private Equity Investor | 02.04.2021 |
| MORGAN STANLEY | Corporate Officer/Principal | 31.12.2006 |
| IONQ, INC. | Director/Board Member | - |
Ausbildung von Blake Byers
| Duke University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MORGAN STANLEY | Finance |
| IONQ, INC. | Electronic Technology |
| Private Unternehmen | 9 |
|---|---|
GV Management Co. LLC
GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Finance |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
IonQ Quantum, Inc.
IonQ Quantum, Inc. Computer Processing HardwareElectronic Technology IonQ Quantum, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jungsang Kim in 2015 and is headquartered in College Park, MD. | Electronic Technology |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
dMY Technology Group, Inc. III
 dMY Technology Group, Inc. III Financial ConglomeratesFinance dMY Technology Group, Inc. III operates as a blank check company. It was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. The company was founded on September 14, 2020 and is headquartered in Las Vegas, NV. | Finance |
| Byers Capital | |
Newlimit, Inc
Newlimit, Inc BiotechnologyHealth Technology Newlimit, Inc has developed a tool that combines various work applications into a single workspace for individuals and teams. The company is located in the US. The American company is also focused on extending human healthspan by unlocking regenerative potential and treating age-related diseases. | Health Technology |
Lendup Global, Inc.
 Lendup Global, Inc. Finance/Rental/LeasingFinance Lendup Global, Inc. engages in the provision of online short term loans. The company was founded by Sasha Orloff and Jacob Rosenberg in 2011 and is headquartered in Oakland, CA. | Finance |
